Telomere Studies
Epithalon has been measured for telomerase activity in cultured human cells.

Pineal + thymic peptide blend · 20 mg lyophilized
Get an email when Epithalon / Thymalin is back
Leave your email and we will send one note the moment it is back in stock.
One email when it restocks, plus occasional Eon updates. Unsubscribe anytime.
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
Researchers also added
Research use only.
This is a blend. Epithalon and Thymalin are combined in a single 20 mg vial, 10 mg of each. Both come from the Soviet peptide bioregulator literature but from different tissues: Epithalon is a defined four amino acid sequence derived from the pineal extract epithalamin, studied for telomerase activity in cultured human cells, while Thymalin is a polypeptide fraction prepared from thymus tissue rather than a single defined sequence. The combination has not been characterised as a single formulation.
Synthetic tetrapeptide + thymic polypeptide fraction (10 mg each)
The numbers that define Epithalon / Thymalin and how it is being studied. For laboratory research use only.
Epithalon · Thymalin
10 mg of each component
Ala-Glu-Asp-Gly
The pathways Epithalon / Thymalin acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
Epithalon is a four amino acid peptide derived from the pineal extract epithalamin. Telomerase activity and telomere length in cultured human cells are the characterised readouts, with sleep-wake timing examined in animal models.
Thymalin is prepared from thymus tissue as a polypeptide fraction rather than a single synthesised sequence. It is characterised at the level of the preparation, so no one amino acid sequence or molecular weight describes it.
The vial pairs a defined synthetic tetrapeptide with a tissue-derived fraction. The two are characterised separately and no interaction data exists for the pair.
The main areas Epithalon / Thymalin is being studied for - and the study-reported figures behind them.
Epithalon has been measured for telomerase activity in cultured human cells.
Thymalin appears in the thymic peptide preparation literature.
Epithalon sleep-wake timing endpoints have been examined in animal models.
One vial holds both compounds under matched handling.
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Molecular model
| Components | Epithalon + Thymalin |
| Content | 20 mg per vial (10 mg of each component) |
| Epithalon | Ala-Glu-Asp-Gly, CAS 307297-39-8 |
| Thymalin | Thymic polypeptide fraction, no single defined sequence |
| Form | Lyophilized powder blend |
| Purity | ≥99% by HPLC |
| Appearance | White to off-white powder |
| Solubility | Water-soluble |
| Storage | -20°C, protected from light |
| Classification | Research use only |
Both come from the same peptide bioregulator literature but from different tissues, pineal and thymic. One vial holds both under matched handling.
Thymalin is a polypeptide fraction prepared from thymus tissue, not a single synthesised peptide. No one amino acid sequence or molecular weight describes it, so none is published here rather than printing a figure that would be wrong.
No. Each compound is characterised separately and no interaction data exists for the pair.
The standalone Epithalon product lets you control its quantity independently and is offered in its own size. This vial fixes the ratio at 10 mg and 10 mg and adds the thymic fraction.
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.